| Tag | Content |
|---|
EnhancerAtlas ID | HS060-12785 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr16:28934880-28935720 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| STAT3 | MA0144.2 | chr16:28935374-28935385 | TTTCCCAGAAG | - | 6.62 | | Stat4 | MA0518.1 | chr16:28935371-28935385 | CTATTTCCCAGAAG | - | 6.16 | | Tcf12 | MA0521.1 | chr16:28934982-28934993 | CAGCAGCTGTT | - | 6.32 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10806 | chr16:28934105-28937640 | CD19_Primary | | SE_11724 | chr16:28932064-28938989 | CD20 | | SE_54362 | chr16:28934039-28937660 | Spleen | | SE_62078 | chr16:28933981-28957654 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TAAGTAAACA GCACAGTAAG TTGTACAAGG ATGTGTCTAC ATTGCACAGG CAGGTGGATC 60
CTGAAATGTG GGAAATACAG CCCCAGAGAA GTCTCCAGCC ACCAGCAGCT GTTAGAAAGG 120
GAAATCGCAT GTTGGGAAGG GAATTTTAGG AAGTTTACTC TGGAAGCCAA TGTCAAGGCC 180
ACACTATAGA GGAAGATCTG TGAGAAGGTT GGGACAAAAG TCCAGGAGAG AGTTGACGAG 240
AGCCCCACCG CAGCAGGGGC ATAGCAGCGG GGGCAGCTCT GACATCTGTT TCAGAGTCTC 300
TGGCTTCTGC TAGAGGAAGG AGAGTAGAAA ACAGGATCAG CAGCTGGGGC GTCTGGGGCC 360
AGAGGACCAA GTACAAAGAA CGTGGGGCGG AGGTGGGGAA GCTGGTGCAT GGCGTGGGGT 420
GGAGGGGGGA GTGTCTGGGG AAGGCTAGAG AGCAGAGCAT TAGACTCACA GAGACTGGGC 480
CAGGGCTGAT TCTATTTCCC AGAAGTCCAG ACTAAAATGA GGTTGGTTTG GGGAACTGAG 540
AAGTTTCTCG CCCATCTTCA GGGTTGATCA ATCATCAGTG AGGGACAAGA AATGACATGG 600
GACAAGGCAA CAGATAGAAG CTGGGAGCTA AACTTAGCTA TAACTGACAG AGCTGCTGCT 660
ATCACATGGA GGGCCTCTAT GCAAATTTTA AAAGGGCGGC CCTTCCTCTG GGCCATAGGC 720
ATGCCCTGTG CCAGGCAGCC CTGCTAACCT ATCCCATAGC TTATCTGTGC CCCCAATCCC 780
TTTCTCGTCA TGCACTCCCC AGTATGGGGT TGATGGGGAG TCTAGGTGAG TCCCGCGTCT 840
|
